Literature DB >> 15972480

Survival of Salmonella enterica serovar Typhimurium within late endosomal-lysosomal compartments of B lymphocytes is associated with the inability to use the vacuolar alternative major histocompatibility complex class I antigen-processing pathway.

Roberto Rosales-Reyes1, Celia Alpuche-Aranda, María de la Luz Ramírez-Aguilar, Angel Denisse Castro-Eguiluz, Vianney Ortiz-Navarrete.   

Abstract

Gamma interferon (IFN-gamma)-activated macrophages use an alternative processing mechanism to present Salmonella antigens to CD8(+) T lymphocytes. This pathway involves processing of antigen in a vacuolar compartment followed by secretion and loading of antigenic peptides to major histocompatibility complex class I (MHC-I) molecules on macrophage cell surface and bystander cells. In this study, we have shown that B lymphocytes are not able to process Salmonella antigens using this alternative pathway. This is due to differences in Salmonella enterica serovar Typhimurium-containing vacuoles (SCV) when comparing late endosomal-lysosomal processing compartments in B lymphocytes to those in macrophages. The IFN-gamma-activated IC21 macrophage cell line and A-20 B-cell line were infected with live or dead Salmonella enterica serovar Typhimurium. The SCV in B cells were in a late endosomal-lysosomal compartment, whereas SCV in macrophages were remodeled to a non-characteristic late endosomal-lysosomal compartment over time. Despite the difference in SCV within macrophages and B lymphocytes, S. enterica serovar Typhimurium survives more efficiently within the IFN-gamma-activated B cells than in activated macrophage cell lines. Similar results were found during in vivo acute infection. We determined that a lack of remodeling of late endosomal-lysosomal compartments by live Salmonella infection in B lymphocytes is associated with the inability to use the alternative MHC-I antigen-processing pathway, providing a survival advantage to the bacterium. Our data also suggest that the B lymphocyte late endosome-lysosome environment allows the expression of Salmonella virulence mechanisms favoring B lymphocytes in addition to macrophages and dendritic cells as a reservoir during in vivo infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972480      PMCID: PMC1168566          DOI: 10.1128/IAI.73.7.3937-3944.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  Live Salmonella modulate expression of Rab proteins to persist in a specialized compartment and escape transport to lysosomes.

Authors:  S Hashim; K Mukherjee; M Raje; S K Basu; A Mukhopadhyay
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

Review 2.  Processing of bacterial antigens for peptide presentation on MHC class I molecules.

Authors:  M J Wick; H G Ljunggren
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

Review 3.  Salmonella: a model for bacterial pathogenesis.

Authors:  M E Ohl; S I Miller
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

Review 4.  Immune response to infection with Salmonella typhimurium in mice.

Authors:  H W Mittrücker; S H Kaufmann
Journal:  J Leukoc Biol       Date:  2000-04       Impact factor: 4.962

5.  Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection.

Authors:  S Bao; K W Beagley; M P France; J Shen; A J Husband
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 6.  Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.

Authors:  U Yrlid; M Svensson; C Johansson; M J Wick
Journal:  FEMS Immunol Med Microbiol       Date:  2000-04

7.  Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium.

Authors:  Y K Oh; C Alpuche-Aranda; E Berthiaume; T Jinks; S I Miller; J A Swanson
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors.

Authors:  F Niedergang; J C Sirard; C T Blanc; J P Kraehenbuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase.

Authors:  A Vazquez-Torres; Y Xu; J Jones-Carson; D W Holden; S M Lucia; M C Dinauer; P Mastroeni; F C Fang
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

10.  Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells.

Authors:  C Driessen; R A Bryant; A M Lennon-Duménil; J A Villadangos; P W Bryant; G P Shi; H A Chapman; H L Ploegh
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

View more
  19 in total

Review 1.  Pathogen manipulation of B cells: the best defence is a good offence.

Authors:  Katharina Nothelfer; Philippe J Sansonetti; Armelle Phalipon
Journal:  Nat Rev Microbiol       Date:  2015-02-09       Impact factor: 60.633

2.  IL-12 Blocks Tfh Cell Differentiation during Salmonella Infection, thereby Contributing to Germinal Center Suppression.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

3.  Direct visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development.

Authors:  Minelva R Nanton; Seung-Joo Lee; Shaikh M Atif; Sean-Paul Nuccio; Justin J Taylor; Andreas J Bäumler; Sing Sing Way; Stephen J McSorley
Journal:  Eur J Immunol       Date:  2014-11-20       Impact factor: 5.532

4.  Salmonella Activation of STAT3 Signaling by SarA Effector Promotes Intracellular Replication and Production of IL-10.

Authors:  Sarah L Jaslow; Kyle D Gibbs; W Florian Fricke; Liuyang Wang; Kelly J Pittman; Mark K Mammel; Joshua T Thaden; Vance G Fowler; Gianna E Hammer; Johanna R Elfenbein; Dennis C Ko
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

5.  A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease.

Authors:  Dennis C Ko; Kajal P Shukla; Christine Fong; Michael Wasnick; Mitchell J Brittnacher; Mark M Wurfel; Tarah D Holden; Grant E O'Keefe; Brian Van Yserloo; Joshua M Akey; Samuel I Miller
Journal:  Am J Hum Genet       Date:  2009-08-06       Impact factor: 11.025

6.  Salmonella Promotes Its Own Survival in B Cells by Inhibiting Autophagy.

Authors:  Lopez-Bailon Luis; Gonzalez-Telona Ana; Galán-Enríquez Carlos; García-Gil Abraham; Estrada-García Iris; Moreno-Lafont Martha; Ortiz-Navarrete Vianney
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

Review 7.  MHC molecules and microbial antigen processing in phagosomes.

Authors:  Lakshmi Ramachandra; Daimon Simmons; Clifford V Harding
Journal:  Curr Opin Immunol       Date:  2009-02-11       Impact factor: 7.486

8.  Antigen-specific B cells reactivate an effective cytotoxic T cell response against phagocytosed Salmonella through cross-presentation.

Authors:  Jelle de Wit; Yuri Souwer; Tineke Jorritsma; Hanny Klaasse Bos; Anja ten Brinke; Jacques Neefjes; S Marieke van Ham
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

9.  B cell activation by outer membrane vesicles--a novel virulence mechanism.

Authors:  Maria Laura A Perez Vidakovics; Johan Jendholm; Matthias Mörgelin; Anne Månsson; Christer Larsson; Lars-Olaf Cardell; Kristian Riesbeck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

10.  Selective infection of antigen-specific B lymphocytes by Salmonella mediates bacterial survival and systemic spreading of infection.

Authors:  Yuri Souwer; Alexander Griekspoor; Jelle de Wit; Chiara Martinoli; Elena Zagato; Hans Janssen; Tineke Jorritsma; Yotam E Bar-Ephraïm; Maria Rescigno; Jacques Neefjes; S Marieke van Ham
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.